Cytokines in experimental colitis
Author:
- 24 December 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 118 (3) , 337-339
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Oral tolerance in diseaseGut, 1999
- Regulation of Autoimmune Diabetes by Interleukin 3-dependent Bone Marrow-derived Cells in NOD MiceJournal of Autoimmunity, 1997
- Predominant pathogenic role of tumor necrosis factor in experimental colitis in miceEuropean Journal of Immunology, 1997
- Functional diversity of helper T lymphocytesNature, 1996
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells.Journal of Experimental Medicine, 1996
- Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease.Journal of Experimental Medicine, 1996
- Antibodies to interleukin 12 abrogate established experimental colitis in mice.Journal of Experimental Medicine, 1995
- Inhibition of Thl responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cellsImmunity, 1994
- Oral Tolerance: Immunologic Mechanisms and Treatment of Animal and Human Organ-Specific Autoimmune Diseases by Oral Administration of AutoantigensAnnual Review of Immunology, 1994